U.S. License Holder:
Vivus Inc.
Date of License:
April-12-2010
Last Update:
Nov-23-2023
FDA-Approved Indications
PANCREAZE (pancrelipase (amylase; lipase; protease)) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.